15Sep
15Sep
Wasabi Featured in 2020 CRN Cloud Partner Program Guide
Wasabi, the hot cloud storage company, today announced that it has been featured in the CRN®, a brand of The Channel Company, 2020 Cloud Partner Program Guide. The annual list identifies industry-leading cloud technology vendors with innovative partner programs that empower and accelerate the growth of solution providers’ cloud initiatives. Read more >>
13Sep
SplitSpot Signs Agreement to Acquire Assets of PlaceMe
SplitSpot, a Boston-based co-living platform, has acquired substantial assets of PlaceMe in a deal recently finalized. With the addition, SplitSpot enhances its position as a co-living leader in Boston, with several hundred rooms on its platform. SplitSpot will immediately transition the operations of a significant amount of the units previously managed by PlaceMe. Read more >>
11Sep
We Need Entrepreneurial Leaders Now More Than Ever
Two years ago, David Zamarin wowed the judges on Shark Tank with a water and stain repellent spray, walking away with $200,000 in investments for his startup Detrapel. When the coronavirus struck, Zamarin applied that same entrepreneurial mindset to a new need, pivoting his companyin a matter of weeks to make hand sanitizer and cleaning products. Read more >>
10Sep
BrandVerge Launches Case Study for IAB NewFronts; Unveils Latest Product Features and Prepares to Promote the Podcast Upfronts
BrandVerge, a premium advertising marketplace for media buyers and sellers, today launched a new case study that demonstrates the success of the private marketplace created exclusively for the IAB NewFronts this past June. Read more >>
09Sep
Regroup Unveils Updated Mass Notification Platform Built to Meet Changing Client Needs
Regroup Mass Notification, an award-winning provider of emergency and day-to-day mass notification technology, today announced the release of its fully updated platform. Read more >>
09Sep
Local Biotech Firm Develops Drug For Respiratory Distress In COVID-19 Patients
Pittsburgh-based biotech company CytoAgents is launching into phase one of clinical trials this month on a drug designed to treat people with COVID-19 who develop serious respiratory distress when their immune system overreacts to the virus. Read more >>
09Sep
Corbus Pharmaceuticals Announces Topline Results from RESOLVE-1 Phase 3 Study of Lenabasum for Treatment of Systemic Sclerosis
Corbus Pharmaceuticals Holdings, Inc., a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today announced topline results from the 52-week Phase 3 RESOLVE-1 study of lenabasum in patients with diffuse cutaneous systemic sclerosis (SSc). Read more >>
05Sep
VC funding update: Boston startups and tech firms raised $1.3B in August
The VC summer slowdown may be real after all. Last month, Boston-area startups and tech firms raised a collective $1.3B—a formidable number, but nothing approximating July’s $6.9B. Waltham-based Pyramid Biosciences raised $8.8M in equity in an $18M funding round, according to an SEC filing. Read more >>
04Sep